D
Dirk Verellen
Researcher at Vrije Universiteit Brussel
Publications - 193
Citations - 7731
Dirk Verellen is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Tomotherapy & Radiation therapy. The author has an hindex of 39, co-authored 157 publications receiving 6663 citations. Previous affiliations of Dirk Verellen include Free University of Brussels & University of Antwerp.
Papers
More filters
Journal ArticleDOI
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Stanley H Benedict,Kamil M. Yenice,David S Followill,James M. Galvin,William H. Hinson,Brian D. Kavanagh,Paul J. Keall,Michael Lovelock,Sanford L. Meeks,Lech Papiez,Thomas G. Purdie,R Sadagopan,Michael C. Schell,Bill J. Salter,David Schlesinger,Almon S. Shiu,Timothy D. Solberg,Danny Y. Song,Volker W. Stieber,Robert Timmerman,Wolfgang A. Tomé,Dirk Verellen,Lu Wang,Fang-Fang Yin +23 more
TL;DR: The task group report includes a review of the literature to identify reported clinical findings and expected outcomes for this treatment modality.
Journal ArticleDOI
Delivering affordable cancer care in high-income countries
Richard Sullivan,Jeffrey Peppercorn,Karol Sikora,John Zalcberg,Neal J. Meropol,Eitan Amir,David Khayat,Peter Boyle,Philippe Autier,Ian F. Tannock,Tito Fojo,Jim Siderov,Steve Williamson,Silvia Camporesi,J. Gordon McVie,Arnie Purushotham,Peter Naredi,Alexander M.M. Eggermont,Murray F. Brennan,Michael L. Steinberg,Mark De Ridder,Susan A. McCloskey,Dirk Verellen,Terence Roberts,Guy Storme,Rodney J. Hicks,Peter J. Ell,Bradford R. Hirsch,David P. Carbone,Kevin A. Schulman,Paul Catchpole,David Taylor,Jan Geissler,Nancy G Brinker,David O. Meltzer,David J. Kerr,Matti Aapro +36 more
TL;DR: Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system.
Journal ArticleDOI
Innovations in image-guided radiotherapy.
TL;DR: With the ability of high-precision dose delivery and real-time knowledge of the target volume location, IGRT has initiated the exploration of new indications for radiotherapy, some of which were previously considered infeasible.
Journal ArticleDOI
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.
Matthias Guckenberger,Nicolaus Andratschke,Karin Dieckmann,Mischa S. Hoogeman,Morten Høyer,Coen W. Hurkmans,Stephanie Tanadini-Lang,Eric Lartigau,Alejandra Méndez Romero,Suresh Senan,Dirk Verellen +10 more
TL;DR: A consensus of risk-adapted SBRT fractionation was achieved with 3×15Gy for peripherally located lesions and 4×12Gy (PTV D95-D99; Dmax <125% to <150%) for lesions with broad chest wall contact, and the maximum tolerated dose of 3×18Gy should be considered.
Journal ArticleDOI
Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging.
Dirk Verellen,Guy Soete,Nadine Linthout,Swana Van Acker,Patsy De Roover,Vincent Vinh-Hung,Jan Van de Steene,Guy Storme +7 more
TL;DR: The stereoscopic X-ray imaging device integrated with the real-time infrared tracking device represents a positioning tool allowing for the geometrical accuracy that is required for conformal radiation therapy of abdominal and pelvic lesions, within an acceptable time-frame.